[go: up one dir, main page]
More Web Proxy on the site http://driver.im/

YU42796A - Farmacetuski preparat koji sadrži ipriflavon, podesan za smanjenje broja cd8+ćelija - Google Patents

Farmacetuski preparat koji sadrži ipriflavon, podesan za smanjenje broja cd8+ćelija

Info

Publication number
YU42796A
YU42796A YU42796A YU42796A YU42796A YU 42796 A YU42796 A YU 42796A YU 42796 A YU42796 A YU 42796A YU 42796 A YU42796 A YU 42796A YU 42796 A YU42796 A YU 42796A
Authority
YU
Yugoslavia
Prior art keywords
cells
ypriflavone
reduction
appropriate
preparation containing
Prior art date
Application number
YU42796A
Other languages
English (en)
Inventor
Attila Kovacs
Peter Aranyi
Tereezia Kerepesi
Attila Tar
Original Assignee
Chinoin Gyogyszer Es Vegyeszeti Termekek Gyara Rt.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Chinoin Gyogyszer Es Vegyeszeti Termekek Gyara Rt. filed Critical Chinoin Gyogyszer Es Vegyeszeti Termekek Gyara Rt.
Publication of YU42796A publication Critical patent/YU42796A/sh

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/335Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/35Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/335Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/35Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
    • A61K31/352Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom condensed with carbocyclic rings, e.g. methantheline 
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00Drugs for immunological or allergic disorders
    • A61P37/02Immunomodulators

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Immunology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicinal Preparation (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Saccharide Compounds (AREA)

Abstract

Predmetni pronalazak se odnosi na farmaceutski preparat podesan za smanjenje broja CD8+ ćelija koji obuhvata kao aktivni sastojak 7-izopropoksiizoflavon u smeši sa podesnim inertnim, čvrstim ili tečnim nosačima i po izboru sa uobičajenim terapeutskim aditivima i pomoćnim agensima. Farmacetuski preparati prema pronalasku se dobivaju poznatim postupcima i podesni su za tretiranje humanih i animalnih subjekata koji su u stanju gde se želi supresija CD8+ limfocita.
YU42796A 1995-07-21 1996-07-19 Farmacetuski preparat koji sadrži ipriflavon, podesan za smanjenje broja cd8+ćelija YU42796A (sh)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
HU9502198A HU9502198D0 (en) 1995-07-21 1995-07-21 Novel indication

Publications (1)

Publication Number Publication Date
YU42796A true YU42796A (sh) 1999-03-04

Family

ID=10987063

Family Applications (1)

Application Number Title Priority Date Filing Date
YU42796A YU42796A (sh) 1995-07-21 1996-07-19 Farmacetuski preparat koji sadrži ipriflavon, podesan za smanjenje broja cd8+ćelija

Country Status (22)

Country Link
EP (1) EP0841915A1 (sh)
JP (1) JP2001503371A (sh)
KR (1) KR19990028933A (sh)
CN (1) CN1191483A (sh)
AR (1) AR002905A1 (sh)
AU (1) AU6367096A (sh)
BG (1) BG102182A (sh)
BR (1) BR9610187A (sh)
CA (1) CA2227421A1 (sh)
CZ (1) CZ2798A3 (sh)
EA (1) EA199800146A1 (sh)
EE (1) EE9800020A (sh)
HR (1) HRP960345A2 (sh)
HU (1) HU9502198D0 (sh)
IL (1) IL122751A0 (sh)
MX (1) MX9800603A (sh)
NO (1) NO980127L (sh)
PL (1) PL324460A1 (sh)
SK (1) SK3298A3 (sh)
WO (1) WO1997003664A1 (sh)
YU (1) YU42796A (sh)
ZA (1) ZA966079B (sh)

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1241079B (it) * 1990-03-23 1993-12-29 Chiesi Farma Spa Composizioni farmaceutiche contenenti ipriflavone,procedimento per la loro preparazione e relativo impiego terapeutico
HU212932B (en) * 1993-08-02 1996-12-30 Chinoin Gyogyszer Es Vegyeszet Parmaceutical composition containing ipriflavone, hydroxyapatit and tricalciumphosphate for treating lack of bones and process for producing the composition

Also Published As

Publication number Publication date
JP2001503371A (ja) 2001-03-13
KR19990028933A (ko) 1999-04-15
WO1997003664A8 (en) 1999-08-05
WO1997003664A1 (en) 1997-02-06
MX9800603A (es) 1998-04-30
PL324460A1 (en) 1998-05-25
NO980127D0 (no) 1998-01-12
EE9800020A (et) 1998-08-17
HU9502198D0 (en) 1995-09-28
EA199800146A1 (ru) 1998-08-27
CZ2798A3 (cs) 1998-06-17
NO980127L (no) 1998-01-12
EP0841915A1 (en) 1998-05-20
AU6367096A (en) 1997-02-18
ZA966079B (en) 1998-01-19
CA2227421A1 (en) 1997-02-06
IL122751A0 (en) 1998-08-16
BG102182A (en) 1998-08-31
SK3298A3 (en) 1998-07-08
BR9610187A (pt) 1998-07-28
AR002905A1 (es) 1998-04-29
HRP960345A2 (en) 1998-02-28
CN1191483A (zh) 1998-08-26

Similar Documents

Publication Publication Date Title
YU47543B (sh) Postupak za dobijanje farmaceutskog preparata za stimulaciju granulocita
NO20005431L (no) Gelerbare farmasoytiske preparater
DE60236611D1 (de) Zahnpflegezusammensetzungen
DE60040753D1 (de) Therapeutische verwendungen von steroiden bei blutzellmangelzustaenden
ATE215827T1 (de) Immunologische aktivität der rhamnolipide
BR9815457A (pt) Kit de partida contendo composições de ácido nicotìnico e uso de ácido nicotìnico em uma formulação de liberação continuada
MD1688G2 (ro) Benzotiofen, benzofuran şi indoltiazepinone, oxazepinone şi diazepinone, compoziţie farmaceutică, metodă de inhibare a aderării leucocitelor la celulele endoteliale pentru tratamentul proceselor inflamatorii şi metodă de tratament al mamiferelor infectate cu HIV infecţie .
DK284386D0 (da) Farmaceutisk praeparat mod hudlidelser
ATE218868T1 (de) Hustenhemmende, theobromine enthaltende zusammensetzungen
IT1170214B (it) Composizione farmaceutica per la cura delle arteriopatie periferiche
ES8400076A1 (es) Procedimiento para hidroformilar compuestos olefinicamente insaturados.
DE69632396D1 (de) Behandlung von erkrankungen, die vom cytokinwachstumsfaktor verursacht werden
KR880007068A (ko) 13-시스 레티노산의 용도
YU42796A (sh) Farmacetuski preparat koji sadrži ipriflavon, podesan za smanjenje broja cd8+ćelija
HRP20060040A2 (en) PURE D-(17α)-13-ETHYL-17-HYDROXY-18,19-DINORPREGN-4-ENE-20-YNE-3-ONE-3E- AND -3Z-OXIME ISOMERS, AS WELL AS PROCESS FOR THE SYNTHESIS OF THE MIXTURE OF ISOMERS AND THE PURE ISOMERS
DK0981363T3 (da) Somatostatinagonister til reduktion af legemsvægt
IT1172264B (it) Enzima simile a pepsina da leucocito umano,procedimento per prepararlo,e composizione terapeutica che lo continene come ingrediente attivo
KR20040049068A (ko) 모발 성장 촉진제 조성물
WO1988007371A3 (en) Prevention and treatment of the deleterious effects of exposing skin to the sun, and compositions therefor
ES2122010T3 (es) Muteinas de amilina.